<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 27.1: Integrative Oncology: Supportive Care and Co-Management | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 60px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: disc;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 list-style: decimal;
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

@media (max-width: 768px) {
 .lesson-wrapper { padding: 12px; }
 .lesson-title { font-size: 28px; }
 .module-header-card { padding: 32px 20px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 27: L3: Specialty Applications</span>
 <h1 class="lesson-title">Integrative Oncology: Supportive Care and Co-Management</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 1 of 8</span>
 <span class="meta-badge">15 min read</span>
 <span class="meta-badge">Specialty Clinical Deep-Dive</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">A</div>
 <div class="asi-text">
 <div class="label">ASI CREDENTIAL VERIFIED</div>
 <div class="title">Certified Integrative Medicine Practitioner™ (CIMP)</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#bridge-oncology"><span class="section-num">01</span>The B.R.I.D.G.E. Framework in Oncology</a></li>
 <li><a href="#tumor-microenvironment"><span class="section-num">02</span>The 'R' Analysis: Tumor Microenvironment</a></li>
 <li><a href="#metabolic-interventions"><span class="section-num">03</span>Metabolic Interventions: FMD & Ketosis</a></li>
 <li><a href="#side-effect-management"><span class="section-num">04</span>Fatigue and Cachexia Management</a></li>
 <li><a href="#synchronization"><span class="section-num">05</span>Synchronizing Interventions</a></li>
 <li><a href="#legal-ethical"><span class="section-num">06</span>Legal and Collaborative Models</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Building on Previous Learning:</strong> In our Level 2 modules, you mastered the synthesis of complex systems. Now, in Level 3, we apply the <strong>B.R.I.D.G.E. Framework™</strong> to highly specialized populations, starting with the most delicate and evidence-sensitive field: Integrative Oncology.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to Lesson 1. Oncology is perhaps the most significant area where the "Integrative" in Integrative Medicine is put to the test. As a practitioner, your role is not to "treat cancer" but to <strong>support the host</strong>, manage treatment-induced toxicity, and optimize the metabolic terrain. This lesson provides the high-level strategies needed to navigate the intersection of conventional oncology and evidence-based supportive care.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Apply 'I' (Integrative Strategy) to synchronize botanical and nutritional interventions with conventional chemotherapy and radiation.</li>
 <li>Utilize 'R' (Root Cause Analysis) to identify metabolic and inflammatory drivers of the tumor microenvironment.</li>
 <li>Evaluate the clinical utility of the Fasting-Mimicking Diet (FMD) and therapeutic ketosis in oncology.</li>
 <li>Implement mitochondrial and lifestyle modifications for cancer-related fatigue and cachexia.</li>
 <li>Navigate the legal and ethical boundaries of collaborative care in an oncology setting.</li>
 </ul>
 </div>

 <h2 id="bridge-oncology">The B.R.I.D.G.E. Framework in Oncology</h2>
 <p>In integrative oncology, the <strong>B.R.I.D.G.E. Framework™</strong> shifts from a search for "root cause" of the cancer itself to a search for the "root cause" of <em>treatment failure</em> or <em>treatment toxicity</em>. We are looking at the <strong>biopsychosocial intake (B)</strong> to assess the patient's resilience and support systems before they undergo aggressive protocols.</p>

 <p>The most critical application here is <strong>Integrative Strategy (I)</strong>. You must understand the pharmacokinetics of chemotherapy. For example, many practitioners mistakenly believe antioxidants should be given *during* radiation to protect the skin. However, radiation relies on oxidative stress to kill cancer cells; high-dose antioxidants may theoretically <span class="highlight">protect the tumor</span> as much as the healthy tissue.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Always prioritize <strong>safety over optimization</strong> during active treatment phases. Many practitioners earn $200+ per hour specifically for "synchronization consulting"—helping patients understand when to stop and start their supplements based on their chemo infusion schedule.</p>
 </div>

 <h2 id="tumor-microenvironment">The 'R' Analysis: Identifying Metabolic Drivers</h2>
 <p>Using <strong>Root Cause Analysis (R)</strong>, we look at the "Soil" vs. the "Seed." While the oncologist focuses on the seed (the tumor), the integrative practitioner focuses on the soil (the tumor microenvironment or TME).</p>

 <p>Key metabolic and inflammatory drivers include:</p>
 <ul>
 <li><strong>Hyperinsulinemia:</strong> Insulin is a potent growth factor. High circulating insulin can stimulate IGF-1 receptors on many tumor types.</li>
 <li><strong>Systemic Inflammation:</strong> Measured via hs-CRP. Chronic inflammation recruits myeloid-derived suppressor cells that help tumors evade the immune system.</li>
 <li><strong>Circadian Disruption:</strong> Melatonin is not just a sleep hormone; it is a potent oncostatic agent. Disrupted sleep cycles can accelerate tumor progression.</li>
 </ul>

 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study 1: Metabolic Terrain Optimization</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 48, Stage II Breast Cancer (ER/PR+). Sarah was experiencing extreme anxiety and high blood sugar (HbA1c 6.1%) following her diagnosis.</p>
 <p><strong>Intervention:</strong> Instead of "treating the cancer," the practitioner focused on <strong>Root Cause (R)</strong>: Metabolic dysfunction. They implemented a low-glycemic, Mediterranean-style diet and used therapeutic breathwork (G: Guided Resilience) to lower cortisol-induced glucose spikes.</p>
 <p><strong>Outcome:</strong> Sarah's HbA1c dropped to 5.4% within 3 months. She reported significantly higher energy during her chemotherapy rounds compared to her peers in the support group, and her oncologist noted her inflammatory markers remained remarkably stable.</p>
 </div>
 </div>

 <h2 id="metabolic-interventions">Metabolic Interventions: FMD & Therapeutic Ketosis</h2>
 <p>One of the most exciting developments in integrative oncology is the use of <strong>Differential Stress Resistance (DSR)</strong>. This concept, championed by Dr. Valter Longo, suggests that healthy cells and cancer cells respond differently to nutrient deprivation.</p>

 <p><strong>The Fasting-Mimicking Diet (FMD):</strong>
 A 2020 study published in <em>Nature Communications</em> (n=131) found that a plant-based FMD administered for 4 days prior to chemotherapy cycles significantly enhanced the tumor-killing effect of the treatment while protecting white blood cells from toxicity.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Intervention</th>
 <th>Mechanism</th>
 <th>Primary Benefit</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>FMD (4-5 days)</strong></td>
 <td>Lowers IGF-1 and Glucose</td>
 <td>Protects healthy cells (DSR)</td>
 </tr>
 <tr>
 <td><strong>Therapeutic Ketosis</strong></td>
 <td>Shifts fuel source to ketones</td>
 <td>May inhibit Warburg Effect in glycolytic tumors</td>
 </tr>
 <tr>
 <td><strong>Time-Restricted Eating</strong></td>
 <td>Autophagy induction</td>
 <td>Reduction in treatment-related inflammation</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Fasting protocols should never be implemented in patients with cachexia or a BMI under 19. In these cases, <strong>Dynamic Lifestyle Modification (D)</strong> focuses on high-density protein and mitochondrial support instead.</p>
 </div>

 <h2 id="side-effect-management">Managing Cancer-Related Fatigue (CRF) and Cachexia</h2>
 <p>Cancer-related fatigue is not "tiredness"; it is a profound <span class="highlight">bioenergetic collapse</span>. Using the <strong>B.R.I.D.G.E. Framework™</strong>, we address this via:</p>
 <ul>
 <li><strong>Mitochondrial Support:</strong> CoQ10, L-Carnitine, and PQQ can be used post-chemotherapy to restore ATP production.</li>
 <li><strong>Vagal Tone (G):</strong> Chronic "Fight or Flight" from the diagnosis drains the HPA axis. Polyvagal techniques are essential for energy conservation.</li>
 <li><strong>Movement as Medicine (D):</strong> Paradoxically, low-intensity movement (like restorative yoga) is the only evidence-based intervention proven to <em>reduce</em> cancer-related fatigue.</li>
 </ul>

 <p><strong>Cachexia</strong> is a metabolic state where the body breaks down muscle despite adequate calorie intake. This is driven by high levels of pro-inflammatory cytokines (TNF-alpha). Omega-3 fatty acids at high doses (2-4g EPA/DHA) have been shown to modulate these cytokines and slow muscle wasting.</p>

 <h2 id="synchronization">Synchronizing Interventions: The 'I' Strategy</h2>
 <p>Timing is the difference between a helpful intervention and a harmful one. Use the following "Rule of Three" for synchronization:</p>
 <ol>
 <li><strong>The 48-Hour Window:</strong> Stop all non-essential supplements 48 hours before chemo and 48 hours after. This ensures no interference with the drug's half-life.</li>
 <li><strong>Antioxidant Gap:</strong> Avoid Vitamin E, Vitamin C (high dose), and NAC during active radiation therapy.</li>
 <li><strong>Botanical Clearance:</strong> Check for CYP450 enzyme interference. For example, St. John's Wort can drastically lower the blood levels of many chemotherapy agents, rendering them ineffective.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Many of your clients will be 40-55 year old women who are terrified. Your <strong>Guided Resilience (G)</strong> tools—like the "Heart-Centered Breath"—are often more valuable in the first 24 hours post-diagnosis than any supplement recommendation.</p>
 </div>

 <h2 id="legal-ethical">Legal and Ethical Considerations</h2>
 <p>As a Certified Integrative Medicine Practitioner™, you must operate within a <strong>Collaborative Care Model</strong>. You are part of a triangle: The Patient, The Oncologist, and You.</p>
 <ul>
 <li><strong>Never use the word "Cure":</strong> We optimize health; we do not cure disease.</li>
 <li><strong>Disclosure:</strong> Encourage the patient to share your protocol with their oncology team. If the oncologist is resistant, provide them with peer-reviewed literature to build a "Bridge" of legitimacy.</li>
 <li><strong>Scope:</strong> You are managing the <em>host</em>, not the <em>disease</em>.</li>
 </ul>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Why is the Fasting-Mimicking Diet (FMD) used specifically in conjunction with chemotherapy?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">FMD induces Differential Stress Resistance (DSR), where healthy cells enter a protective "shielded" state while cancer cells remain vulnerable to the chemotherapy, potentially increasing efficacy while reducing side effects like leukopenia.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the primary concern with high-dose antioxidants during radiation therapy?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">Radiation works by creating reactive oxygen species (ROS) to damage tumor DNA. High-dose antioxidants can neutralize these ROS, potentially protecting the tumor from the treatment's intended effects.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which metabolic marker is a potent growth factor for many tumors and should be a focus of 'R' (Root Cause Analysis)?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">Insulin (and IGF-1). Hyperinsulinemia provides a growth signal to many cancers, making blood sugar management a cornerstone of integrative oncology.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What is the recommended "safety window" for stopping supplements around chemotherapy infusions?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">A 48-hour window before and after the infusion is a standard conservative approach to avoid pharmacokinetic or pharmacodynamic interference.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Integrative oncology focuses on supporting the host and the metabolic terrain, not treating the tumor directly.</li>
 <li>The B.R.I.D.G.E. Framework™ helps synchronize interventions to avoid interference with conventional protocols.</li>
 <li>Metabolic strategies like FMD and ketosis utilize Differential Stress Resistance to protect healthy tissue.</li>
 <li>Managing inflammation (hs-CRP) and insulin levels is a critical 'R' (Root Cause) strategy for the tumor microenvironment.</li>
 <li>Always maintain a collaborative relationship with the oncology team to ensure patient safety and professional legitimacy.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>de Groot, S. et al. (2020). "Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial." <em>Nature Communications</em>.</li>
 <li>Longo, V. D., & Fontana, L. (2018). "Intermittent Fasting and Cancer: Mechanisms and Clinical Outcomes." <em>Cell Metabolism</em>.</li>
 <li>Block, K. I. et al. (2008). "Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials." <em>Cancer Treatment Reviews</em>.</li>
 <li>Mishra, S. I. et al. (2012). "Exercise interventions for cancer-related fatigue." <em>Cochrane Database of Systematic Reviews</em>.</li>
 <li>Zick, S. M. et al. (2018). "Integrative Oncology: Standard of Care for Cancer Patients." <em>Journal of the National Cancer Institute Monographs</em>.</li>
 <li>Fearon, K. et al. (2011). "Definition and classification of cancer cachexia: an international consensus." <em>The Lancet Oncology</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>